Gold futures hit a record $3,540 as global central banks' gold holdings surpassed U.S. Treasury bonds for the first time since 1996, amid expectations of a Federal Reserve interest rate cut.

Gold prices hit a record high above $3500 per ounce amid expectations of a US interest rate cut in September. Other precious metals showed mixed price movements.

Global bond markets have seen sharp volatility this year with rapid fluctuations. Long-term bond yields hit record highs in Japan, the US, and Europe amid investor concerns about fiscal and monetary policies.

Salam Telecommunications Union Company hosts data within Saudi Arabia and adheres to the highest governance standards to support Vision 2030, adopting the "Cybersecurity by Design" approach and leveraging AI to enhance cybersecurity.

Singapore has criminalized the possession and use of electronic cigarettes, imposing strict penalties including fines and imprisonment. The Egyptian immigration sector warns travelers to comply with local laws to avoid violations.

The Suez Canal Economic Zone signed a contract with a Chinese company to build a ready-made garments factory in West Kantara with an $8 million investment, aiming to produce 16.5 million pieces annually and create 2,000 jobs, with all production dedicated to export.

The Ministry of Trade reported over 7,368 economic violations in August 2025, while confirming stable supply in markets except for some subsidized products like coffee and sugar, which were managed by supplying exceptional quantities.

Gold reached a new peak above $3,500, supported by expectations of a US interest rate cut this month amid ongoing political and economic tensions. Investors await US jobs data to determine the expected rate cut size.

Financial coach Hussein Al-Harbi warns that lack of early financial planning leads to loss of financial and social stability after retirement, emphasizing that planning and regular saving can turn retirement into a stable and successful new phase.

King Faisal Specialist Hospital in Riyadh has successfully treated the first patient using locally manufactured genetically modified T cells in a clinical trial for resistant acute lymphoblastic leukemia patients.